课题基金 / 基金详情

METABOLIC EFFECTS OF NEWER ANTIPSYCHOTICS IN OLDER PATIENTS

METABOLIC EFFECTS OF NEWER ANTIPSYCHOTICS IN OLDER PATIENTS
新型抗精神病药对老年患者的代谢影响
批准号:
8166806
负责人:
DILIP V. JESTE
金额:
$6.83万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2010-06-30

项目摘要

项目成果

DILIP V. JESTE的其他基金

相关文献

中文摘要
翻译
该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得主要资金, 因此可以在其他CRISP条目中表示。列出的机构是 中心,不一定是研究者的机构。 比较阿立哌唑、奥氮平、奎替利嗪和利培酮4种非典型药物在中老年患者中发生MCCE的风险。 检查抗精神病药诱导的MCCE对日常功能和生活质量的影响。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Compare the risk of MCCE associated with four atypical agents: aripiprazole, olanzapine, quetiapine, and risperidone in middle aged and elderly patients. Examine the impact of anitpsychotic induced MCCE on everyday functioning and quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-component Intervention for Diabetes in Adults with Serious Mental Illness (MIDAS)
Sustained Training in Aging and HIV Research (STAHR)
Sustained Training in Aging and HIV Research (STAHR)
Sustained Training in Aging and HIV Research (STAHR)